Related Experiment Videos
p63 and p73: teammates or adversaries?
Edward Ratovitski1, Barry Trink, David Sidransky
1Department of Otolaryngology-Head and Neck Surgery, Division of Head and Neck Cancer Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Cancer Cell
|January 18, 2006
Summary
The p63 protein promotes cancer cell survival by blocking the cancer-cell-killing function of the p73 protein in head and neck squamous cell carcinomas (HNSCC). This discovery highlights p63 and p73 as potential therapeutic targets for HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The p53 protein family, including p63 and p73, plays a crucial role in regulating cell fate and tumor suppression.
- Dysregulation of p53 family members is frequently observed in various cancers, including head and neck squamous cell carcinomas (HNSCC).
- Understanding the intricate interplay between p63 and p73 is essential for deciphering cancer progression mechanisms.
Purpose of the Study:
- To elucidate the functional relationship between p63 and p73 in the context of DNA damage response in HNSCC.
- To investigate the role of p73 in the regulation of proapoptotic genes, such as Puma, Noxa, and Bcl-2, within HNSCC.
- To define a molecular pathway involving p63 and p73 that influences tumor cell survival or death.
Main Methods:
- The study likely involved molecular biology techniques such as Western blotting, immunoprecipitation, and gene expression analysis.
- Cellular assays to assess apoptosis and cell survival following DNA damage were probably employed.
- Analysis of tumor samples or cell lines derived from head and neck squamous cell carcinomas (HNSCC) was central to the investigation.
Main Results:
- The findings reveal that deltaNp63alpha, a specific isoform of p63, actively promotes the survival of squamous epithelial cancer cells.
- This survival mechanism is achieved by repressing a transcriptional program that is dependent on p73 and normally induces apoptosis.
- p73 was identified as a key regulator of proapoptotic factors like Puma, Noxa, and Bcl-2 in HNSCC.
Conclusions:
- The deltaNp63alpha isoform of p63 functions as a survival factor in HNSCC by inhibiting p73-mediated apoptosis.
- The status and levels of p63 and p73 are critical determinants of tumor cell fate and response to therapy in HNSCC patients.
- Targeting the p63/p73 pathway presents a potential therapeutic strategy for HNSCC treatment.